4//SEC Filing
Bisker-Leib Vered 4
Accession 0001171843-23-007223
CIK 0001738021other
Filed
Nov 20, 7:00 PM ET
Accepted
Nov 21, 2:10 PM ET
Size
5.6 KB
Accession
0001171843-23-007223
Insider Transaction Report
Form 4
Bisker-Leib Vered
Chief Operating Officer
Transactions
- Tax Payment
Common Stock
2023-11-17$1.50/sh−64,415$96,623→ 1,420,499 total
Footnotes (2)
- [F1]Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs")
- [F2]8,148 of these shares of common stock underlie unvested restricted stock awards that are subject to a right of repurchase in favor of the issuer, which will vest on November 30 and December 31, 2023. 300,000 of the shares represents unvested restricted stock units ("RSU") granted to the reporting person on November 16, 2021. 400,000 of the shares represents unvested restricted stock units ("RSU") granted to the reporting person on February 8, 2023. Each RSU represents a contingent right to receive one share of common stock. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first installment vested on November 15, 2022.
Documents
Issuer
Compass Therapeutics, Inc.
CIK 0001738021
Entity typeother
Related Parties
1- filerCIK 0001814093
Filing Metadata
- Form type
- 4
- Filed
- Nov 20, 7:00 PM ET
- Accepted
- Nov 21, 2:10 PM ET
- Size
- 5.6 KB